Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 1/2005

01-01-2005 | Brief Report

A particular hepatitis C virus protease NS3 gene pattern in a patient not responding to interferon-ribavirin therapy

Authors: S. Vallet, J. B. Nousbaum, S. Gouriou, M. C. Legrand-Quillien, A. Goudeau, B. Picard

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 1/2005

Login to get access

Excerpt

Hepatitis C virus (HCV) is characterized by a high degree of genetic heterogeneity. This is a consequence of its rapid turnover in vivo and of the low fidelity of its RNA-dependent RNA polymerase, which lacks proofreading activity. Its high propensity to mutate is also reflected by the existence of closely related genomes, known as quasispecies [1]. NS3 protease is essential for HCV replication. It acts via a catalytic triad consisting of a histidine, an aspartate and a serine. It is also one of the most promising targets for specific anti-HCV therapy [2]. Although the NS3 protease is considered to be one of the least variable genes in the HCV genome, we previously found an appreciable polymorphism in this genomic region in 294 HCV genotype 1 clones isolated from the serum of 17 infected patients [3]. Reported here is a particular pattern, including three deletions and one insertion, found in four clones among 19 NS3 protease variants of a quasispecies detected in one of these patients. …
Literature
1.
go back to reference Martell M, Esteban JI, Quer J, Genesca J, Weiner A, Esteban R, Guardia J, Gomez J (1992) Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 66:3225–3229 Martell M, Esteban JI, Quer J, Genesca J, Weiner A, Esteban R, Guardia J, Gomez J (1992) Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 66:3225–3229
2.
go back to reference Lamarre D, Anderson PC, Bailey M, Beaulieu P, Bolger G, Bonneau P, Bos M, Cameron DR, Cartier M, Cordingley MG, Faucher AM, Goudreau N, Kawai SH, Kukolj G, Lagace L, LaPlante SR, Narjes H, Poupart MA, Rancourt J, Sentjens RE, St George R, Simoneau B, Steinmann G, Thibeault D, Tsantrizos YS, Weldon SM, Yong CL, Llinas-Brunet M (2003) An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus. Nature 426:186–189CrossRefPubMed Lamarre D, Anderson PC, Bailey M, Beaulieu P, Bolger G, Bonneau P, Bos M, Cameron DR, Cartier M, Cordingley MG, Faucher AM, Goudreau N, Kawai SH, Kukolj G, Lagace L, LaPlante SR, Narjes H, Poupart MA, Rancourt J, Sentjens RE, St George R, Simoneau B, Steinmann G, Thibeault D, Tsantrizos YS, Weldon SM, Yong CL, Llinas-Brunet M (2003) An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus. Nature 426:186–189CrossRefPubMed
3.
go back to reference Vallet S, Gouriou S, Nousbaum JB, Legrand-Quillien MC, Goudeau A, Picard B (2005) Genetic heterogeneity of the NS3 protease gene in hepatitis C virus genotype 1 from untreated patients. J Med Virol (in press) Vallet S, Gouriou S, Nousbaum JB, Legrand-Quillien MC, Goudeau A, Picard B (2005) Genetic heterogeneity of the NS3 protease gene in hepatitis C virus genotype 1 from untreated patients. J Med Virol (in press)
4.
go back to reference Condit RC (2001) Principles of virology. In: Knipe DM, Howley PM (eds) Fields virology. Lippincott Williams and Wilkins, Philadelphia, PA, pp 19–51 Condit RC (2001) Principles of virology. In: Knipe DM, Howley PM (eds) Fields virology. Lippincott Williams and Wilkins, Philadelphia, PA, pp 19–51
5.
go back to reference Higashi Y, Kakumu S, Yoshioka K, Wakita T, Mizokami M, Ohba K, Ito Y, Ishikawa T, Takayanagi M, Nagai Y (1993) Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. Virology 197:659–668 Higashi Y, Kakumu S, Yoshioka K, Wakita T, Mizokami M, Ohba K, Ito Y, Ishikawa T, Takayanagi M, Nagai Y (1993) Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. Virology 197:659–668
6.
go back to reference Ruster B, Zeuzem S, Roth WK (1996) Hepatitis C virus sequences encoding truncated core proteins detected in a hepatocellular carcinoma. Biochem Biophys Res Commun 219:911–915 Ruster B, Zeuzem S, Roth WK (1996) Hepatitis C virus sequences encoding truncated core proteins detected in a hepatocellular carcinoma. Biochem Biophys Res Commun 219:911–915
7.
go back to reference Yeh CT, Lu SC, Chu CM, Liaw YF (1997) Molecular cloning of a defective hepatitis C virus genome from the ascitic fluid of a patient with hepatocellular carcinoma. J Gen Virol 78(Pt 11):2761–2770 Yeh CT, Lu SC, Chu CM, Liaw YF (1997) Molecular cloning of a defective hepatitis C virus genome from the ascitic fluid of a patient with hepatocellular carcinoma. J Gen Virol 78(Pt 11):2761–2770
Metadata
Title
A particular hepatitis C virus protease NS3 gene pattern in a patient not responding to interferon-ribavirin therapy
Authors
S. Vallet
J. B. Nousbaum
S. Gouriou
M. C. Legrand-Quillien
A. Goudeau
B. Picard
Publication date
01-01-2005
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 1/2005
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-004-1269-3

Other articles of this Issue 1/2005

European Journal of Clinical Microbiology & Infectious Diseases 1/2005 Go to the issue

Announcements

Announcements